Αποτελέσματα Αναζήτησης
Giving insight in the vaccine schedules in all countries of the EU, provided by the European Centre for Disease Prevention and Control (ECDC).
- Contact
Giving insight in the vaccine schedules in all countries of...
- Contact
The Vaccine Scheduler is an interactive tool that shows vaccination schedules for individual EU/EEA countries and specific age groups.
The live attenuated Oka strain VZV vaccine reduces the incidence of HZ, PHN and their associated burden-of-illness (BOI) among people ≥50 years of age,4–7 but the Advisory Committee on Immunization Practices (ACIP) recommends the vaccine only for adults aged ≥60 years,8 in part because the vaccine appears not to be cost-effective below ...
14 Μαΐ 2019 · Prevention of HSV-2 infection would prevent associated GUD and HSV transmission, including to neonates as neonatal herpes, as well as HSV-2-associated HIV acquisition. PPCs for therapeutic HSV vaccines that reduce symptomatic HSV-2 GUD in individuals who are already infected with HSV-2.
3 Ιουν 2016 · We will provide an overview of efforts to develop HSV-2 vaccines, including a discussion of the clinical need for an HSV vaccine, and status of research and development with an emphasis on recent insights from trials of vaccine candidates in clinical testing.
Adjuvanted Hepatitis B vaccine (HepB-CgG) can be administered to adults 18 years old and older on a two dose schedule, the first and second dose separated by 4 weeks. HepB-3 should be administered at least 8 weeks after HepB-2 and at least 16 weeks after HepB-1 and should not be administered before age 24 weeks.
These schedules indicate the recommended age groups and medical indications for which administration of currently licensed vaccines is commonly recommended for adults aged ≥19 years, as of February 2016.
